Elbit Systems
ESLT
669.13
-21.97
-3.18%
Elbit Systems
US · ESLT
#642 by market cap
Listed 1970
669.13
-21.97
-3.18%
Live - 5344 symbols - heartbeat 402s ago
· 2026-10-08 06:25
Pre-market
664.20
-0.74%
After-hours
669.13
0.00%
- Market cap
- 31.36B
- P/E (TTM)i
- 50.35
- P/Bi
- 7.11
- EPSi
- 11.39
- Div yieldi
- 0.52%
- 52W posi
- 39%
Reader sentiment
Are you bullish or bearish on ESLT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.53, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +16.27% YoY
Margins
- Gross margin
- 24.38%
- Operating margin
- 8.66%
- Net margin
- 6.73%
Key ratios & quality
- Enterprise valuei
- 31.03B
- PEG ratioi
- 2.04
- Altman Z-Scorei
- 3.53
PEG uses trailing P/E against the 3-year net income growth rate (24.72%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.68B | 4.51B | 4.66B | 5.28B | 5.51B | 5.97B | 6.83B | 7.94B |
| Gross profit | 976.18M | 1.14B | 1.17B | 1.36B | 1.37B | 1.48B | 1.64B | 1.94B |
| Selling & admin expenses | 445.16M | 527.07M | 528.28M | 570.83M | 643.62M | 696.02M | 665.46M | 730.93M |
| Research & development | 287.35M | 331.76M | 359.75M | 395.09M | 435.65M | 424.42M | 466.40M | 517.14M |
| Operating profit | 289.04M | 310.69M | 312.04M | 406.79M | 362.93M | 362.51M | 509.96M | 687.18M |
| Pretax profit | 237.32M | 246.30M | 261.83M | 383.45M | 292.56M | 226.49M | 341.75M | 561.92M |
| Tax | 26.45M | 19.41M | 36.44M | 131.39M | 24.13M | 22.91M | 39.06M | 55.54M |
| Net profit | 208.66M | 228.66M | 237.99M | 274.66M | 275.47M | 215.86M | 321.86M | 535.62M |
| Basic EPS | 5 | 5 | 5 | 6 | 6 | 5 | 7 | 12 |
| Diluted EPS | 4.83 | 5.20 | 5.38 | 6.20 | 6.18 | 4.82 | 7.18 | 11.39 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.90B | 1.97B | 1.92B | 2.15B | 2.19B | 2.29B |
| Gross profit | 454.31M | 472.91M | 478.24M | 529.79M | 552.06M | 579.01M |
| Selling & admin expenses | 190.33M | 185.43M | 177.70M | 177.48M | 196.54M | 201.09M |
| Research & development | 114.27M | 129.67M | 129.11M | 144.10M | 150.39M | 159.12M |
| Operating profit | 149.71M | 157.82M | 171.43M | 208.22M | 205.13M | 218.79M |
| Pretax profit | 115.70M | 125.30M | 138.33M | 182.59M | 174.66M | 198.99M |
| Tax | 16.06M | 7.06M | 11.41M | 21.01M | 22.77M | 32.71M |
| Net profit | 107.37M | 126.02M | 133.68M | 168.55M | 160.86M | 173.53M |
| Basic EPS | 2 | 3 | 3 | 4 | 3 | 4 |
| Diluted EPS | 2.35 | 2.69 | 2.80 | 3.52 | 3.34 | 3.61 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.28B | 3.67B | 4.27B | 4.98B | 5.03B | 5.51B | 6.36B | 7.74B |
| Cash & ST investments | 224.93M | 223.27M | 280.32M | 260.18M | 212.15M | 207.95M | 266.68M | 815.75M |
| Inventory | 1.05B | 1.11B | 1.22B | 1.49B | 1.69B | 2.03B | 2.36B | 2.73B |
| Total assets | 6.45B | 7.34B | 8.06B | 9.32B | 9.22B | 9.74B | 10.97B | 12.66B |
| Total current liabilities | 2.91B | 3.17B | 3.62B | 4.02B | 4.28B | 4.82B | 5.31B | 5.98B |
| Short-term debt | 271.37M | 470.85M | 396.49M | 183.14M | 260.95M | 719.27M | 610.33M | 232.45M |
| Long-term debt | 523.95M | 440.12M | 408.82M | 884.95M | 680.08M | 384.07M | 305.92M | 255.63M |
| Total liabilities | 4,596,377,000.00 | 5,175,518,000.00 | 5,826,530,000.00 | 6,771,081,000.00 | 6,457,976,000.00 | 6,789,291,000.00 | 7,690,616,000.00 | 8,531,545,000.00 |
| Total equity | 1.85B | 2.16B | 2.23B | 2.55B | 2.76B | 2.95B | 3.28B | 4.13B |
| Retained earnings | 1.69B | 1.86B | 2.00B | 2.20B | 2.38B | 2.51B | 2.74B | 3.15B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.80B | 7.32B | 7.44B | 7.74B | 8.31B | 8.87B |
| Cash & ST investments | 455.14M | 848.91M | 735.63M | 815.75M | 925.27M | 962.94M |
| Inventory | 2.87B | 2.95B | 3.15B | 2.73B | 3.24B | 3.24B |
| Total assets | 11.36B | 12.10B | 12.28B | 12.66B | 13.23B | 13.86B |
| Total current liabilities | 5.64B | 5.69B | 5.64B | 5.98B | 5.91B | 6.36B |
| Short-term debt | 665.78M | 529.57M | 346.56M | 232.45M | 179.27M | 184.49M |
| Long-term debt | 295.39M | 246.22M | 249.63M | 255.63M | 248.26M | 179.98M |
| Total liabilities | 8,046,933,000.00 | 8,150,952,000.00 | 8,260,865,000.00 | 8,531,545,000.00 | 8,971,667,000.00 | 9,448,630,000.00 |
| Total equity | 3.31B | 3.95B | 4.02B | 4.13B | 4.26B | 4.41B |
| Retained earnings | -- | -- | -- | 3.15B | -- | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 191.66M | -53.32M | 278.83M | 416.93M | 240.07M | 113.71M | 534.61M | 778.38M |
| Depreciation & amortization | 118.21M | 137.15M | 144.42M | 153.09M | 161.29M | 164.80M | 158.39M | 171.43M |
| Free cash flow | 89.36M | -190.92M | 146.62M | 228.31M | 34.96M | -73.33M | 319.56M | 552.81M |
| Dividends paid | -75.31M | -62.58M | -78.19M | -79.18M | -86.81M | -89.25M | -88.96M | -111.69M |
| Stock buybacks / issuance | 0 | 184.84M | -- | -- | -- | 30.00K | 26.00K | 573.06M |
| Ending cash balance | 208.48M | 221.06M | 278.79M | 258.99M | 211.11M | 197.43M | 265.35M | 635.14M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 183.58M | 120.40M | 157.08M | 317.33M | 281.05M | 236.73M |
| Depreciation & amortization | 41.88M | 43.38M | 43.57M | 42.61M | 45.82M | 47.71M |
| Free cash flow | 160.91M | 70.59M | 101.17M | 220.15M | 209.89M | 150.34M |
| Dividends paid | -22.27M | -26.83M | -27.80M | -34.79M | -35.34M | -46.44M |
| Stock buybacks / issuance | 37.00K | 572.96M | 21.00K | 43.00K | 33.00K | 103.00K |
| Ending cash balance | 113.68M | 109.11M | 142.59M | 635.14M | 155.25M | 255.34M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.68 | 11.47 | 10.90 | 11.55 | 10.42 | 7.54 | 10.32 | 14.43 |
| ROA %i | 3.70 | 3.31 | 3.09 | 3.16 | 2.97 | 2.27 | 3.10 | 4.52 |
| ROIC %i | 9.66 | 8.41 | 7.57 | 7.83 | 7.74 | 6.66 | 9.63 | 12.18 |
| 5-year avg ROE %i | 14.41 | 13.86 | 12.95 | 12.05 | 11.20 | 10.38 | 10.15 | 10.85 |
| EBIT margin %i | 7.21 | 6.09 | 6.13 | 7.72 | 6.01 | 5.07 | 6.95 | 7.98 |
| FCF / sales %i | 2.43 | -- | 3.14 | 4.33 | 0.63 | -- | 4.68 | 6.96 |
| Current ratioi | 1.13 | 1.16 | 1.18 | 1.24 | 1.18 | 1.14 | 1.20 | 1.29 |
| Quick ratioi | 0.70 | 0.75 | 0.80 | 0.79 | 0.69 | 0.63 | 0.64 | 0.73 |
| Debt / assetsi | 12.33 | 16.83 | 14.93 | 15.61 | 13.95 | 15.06 | 12.49 | 7.62 |
| LT debt / equityi | 28.59 | 35.65 | 36.37 | 50.23 | 37.19 | 25.35 | 23.19 | 17.73 |
| Interest coveragei | 9.39 | 9.74 | 11.94 | 16.80 | 8.51 | 3.96 | 3.58 | 8.85 |
| Revenue CAGR (3Y) %i | 5.83 | 11.41 | 11.34 | 12.74 | 6.93 | 8.62 | 8.96 | 12.93 |
| Net income CAGR (3Y) %i | 0.69 | -1.29 | -0.20 | 9.89 | 6.53 | -3.27 | 5.39 | 24.72 |
| FCF CAGR (3Y) %i | -35.67 | -- | -- | 36.71 | -- | -- | 11.86 | 151.00 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.23 | 11.54 | 12.88 | 14.43 | 15.55 | 15.23 |
| ROA %i | 3.28 | 3.55 | 3.95 | 4.52 | 4.78 | 4.90 |
| ROIC %i | 10.35 | 10.84 | 11.84 | 12.18 | 13.13 | 13.12 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.23 | 7.46 | 7.78 | 7.98 | 8.33 | 8.78 |
| FCF / sales %i | 7.91 | 8.52 | 9.54 | 6.96 | 7.31 | 7.97 |
| Current ratioi | 1.21 | 1.29 | 1.32 | 1.29 | 1.41 | 1.39 |
| Quick ratioi | 0.70 | 0.77 | 0.76 | 0.73 | 0.86 | 0.89 |
| Debt / assetsi | 12.23 | 10.21 | 8.71 | 7.62 | 6.76 | 6.15 |
| LT debt / equityi | 21.87 | 17.90 | 18.01 | 17.73 | 16.80 | 15.14 |
| Interest coveragei | 3.69 | 3.93 | 4.55 | 8.85 | 10.58 | 13.47 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Land is the largest reported line at 33.68% of revenue, across 6 reported segments.
- No single line clears half of revenue; Aerospace is next at 21.64%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Land33.68%
Aerospace21.64%
Elbit Systems of America (ESA)20.85%
Intelligence, Surveillance, Target Acquisition and Reconnaissance (ISTAR) and Electronic warfare(EW)19.58%
Command, control, communications, computer, intelligence (C4I) and Cyber11.06%
Quote time 2026-10-08 06:25:19 · For reference only, not investment advice and not tailored to your situation.